Mon, Jul 14, 2014, 12:21 PM EDT - U.S. Markets close in 3 hrs 39 mins


% | $
Quotes you view appear here for quick access.

Threshold Pharmaceuticals Inc. Message Board

  • thanhle_00 thanhle_00 Jan 3, 2007 2:48 PM Flag

    I can't believe..

    we are giving back everything we gained in the past few sessions. What a bunch of morons...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The stock is in the hands of the traders now, who will create volatility as long as the fundamentals don't change or as long as volume remains strong. While it would have been nice to see the stock hold in the $4's until phase III, there probably aren't enough institutions willing to take on the risk and retail support is probably lean due to the "underwhelming" phase II results (underwhelming in that most people don't understand that 20% partial response and 30% stable disease is actually excellent when compared to existing treatments). Any way, unless you get an analyst that goes out on a limb (which they probably won't before the phase III results), we will be in the hands of the traders. They'll get bored when the volume dries up.

    • should fill the gap, either bounce or languish and then set up for big move based on P3. All imo.

    • don't complain, just back up the truck, these opportunities don't come along every day.

    • who are the morans here us or them.... well at leats i was able to make a couple of dollars on our recent 30% gain.. just as the great leader jimmy cramer says pigs get slaughtered... lol.... thinking of loading up here and possibly again if we go below $3...

    • Why can't you believe it? Initially, speculators and day traders jumped in when they saw the headlines of "positive results". Now, analysts have asked oncologists to review data and give their opinion. A limited study of 28 patients with 10 showing a "partial response". Hardly something to get over-excited about (unbridled enthusiasm?). True, anything that is helpful in anyway without it causing major toxicity for pancreatic cancer will be useful. However, the next Phase of clinical testing (which involves a more difficult group of patients) will be necessary to give Glufo more credibility. i certainly hope this does come to fruition, but right now shorting of THLD after it hit a PPS of 4 was just what the doctor ordered. IMO: if you bought THLD before the run-up, hold on; it may prove later on to be well-worth the money. If you bought on the hype--you have a decision to make; just don't expect "to the moon", just not yet.

    • It happens a lot. I short stocks like this every so often and always make out. This is just working out quicker and better than most (even beyond my expectations).

      Pardon me if I'm a little excited. I'm up over 20% already. Excellent way to start the year.

4.27+0.09(+2.15%)12:18 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.